Neurogene (NGNE) Retained Earnings (2013 - 2026)

Neurogene (NGNE) has 14 years of Retained Earnings data on file, last reported at $621.4 million in Q1 2026.

• Quarterly Retained Earnings rose 318.07% year-over-year to $621.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $621.4 million (up 318.07% YoY) and the FY2025 annual result came in at $617.5 million, up 7.83% from the prior year.
• Retained Earnings improved to $621.4 million in Q1 2026, from $617.5 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $621.4 million in Q1 2026 to a low of -$327.9 million in Q3 2025.
• A 5-year average of $164.6 million and a median of $5.1 million in 2022 frame the typical range for Retained Earnings.
• The widest YoY moves for Retained Earnings: up 759729.17% in 2023, down 3771.13% in 2023.
• Tracing NGNE's Retained Earnings over 5 years: stood at $5.1 million in 2022, then sank by 3771.13% to -$187.2 million in 2023, then soared by 405.99% to $572.7 million in 2024, then gained by 7.83% to $617.5 million in 2025, then increased by 0.62% to $621.4 million in 2026.
• The last three Retained Earnings figures came in at $621.4 million (Q1 2026), $617.5 million (Q4 2025), and -$327.9 million (Q3 2025), per Business Quant data.